InChI=1S/C32H36N2O4/c1- 18- 8- 7- 9- 23- 15- 19(2) 21(4) 29- 26(16- 22- 17- 33- 25- 11- 6- 5- 10- 24(22) 25) 34- 31(38) 32(23,29) 28(36) 13- 12- 27(35) 30(37) 20(3) 14- 18/h5- 7,9- 15,17- 18,21,23,26,29- 30,33,37H,8,16H2,1- 4H3,(H,34,38) /b9- 7+,13- 12+,20- 14+/t18- ,21+,23- ,26- ,29- ,30+,32+/m0/s1 |
XSYISNGSIFFBMR-YGCMOINNSA-N |
C[C@H] 1[C@H] 2[C@H] (Cc3c[nH] c4ccccc34) NC(=O) [C@@] 22[C@H] (C=C1C) \C=C\C[C@H] (C) \C=C(C) \[C@@H] (O) C(=O) \C=C\C2=O |
|
Chaetomium globosum
(NCBI:txid38033)
|
See:
PubMed
|
Chaetomium metabolite
Any fungal metabolite produced during a metabolic reaction in the mould, Chaetomium.
fungal metabolite
Any eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
(via cytochalasan alkaloid )
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via alkaloid )
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(3S,3aR,4S,6aS,7E,10S,11E,13R,15E,17aS)- 13- hydroxy- 3- (1H- indol- 3- ylmethyl)- 4,5,10,12- tetramethyl- 2,3,3a,4,6a,9,10,13- octahydro- 1H- cyclotrideca[d]isoindole- 1,14,17- trione
|
65745-47-3
|
CAS Registry Number
|
ChemIDplus
|
735570
|
Reaxys Registry Number
|
Reaxys
|
15497948
|
PubMed citation
|
Europe PMC
|
|